1982
DOI: 10.1038/bjc.1982.34
|View full text |Cite
|
Sign up to set email alerts
|

Cells bearing Fc receptors in human malignant solid tumours

Abstract: Summary.-Fc-receptor-bearing cells forming EA rosettes with antibody-coated human erythrocytes (Ripley) were studied in cell suspensions and in purified preparations of mononuclear cells (MC) from 20 human malignant tumours.The EA rosettes were studied in preparations made by cytocentrifugation and the rosette-forming cells identified by their nonspecific-esterase activity and phagocytic capacity.Fc receptors were found on 16+20% of all cells in the primary cell suspensions.Significantly more tumour-infiltrati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
5
0

Year Published

1984
1984
2013
2013

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(5 citation statements)
references
References 26 publications
0
5
0
Order By: Relevance
“…In addition, it was observed that tumor cells injected in mice immunized with non-tumoral antigens were able to bind antibody via their Fc region [ 53 ]. However, the ectopic expression of Fc γ R by non-hematopoietic tumors cells was controversial because the presence of inflammatory cells, which can express Fc γ R, was demonstrated early at the tumor site [ 54 ] and because Fc γ R expression was lost during short-term tumor cell in vitro culture [ 55 ]. Nevertheless, it was shown that the experimental tumors regained expression after a single passage in vivo [ 56 ] and that some tumor cell lines express Fc γ R [ 57 ].…”
Section: Expression Of Tumor Fc γ Riibmentioning
confidence: 99%
“…In addition, it was observed that tumor cells injected in mice immunized with non-tumoral antigens were able to bind antibody via their Fc region [ 53 ]. However, the ectopic expression of Fc γ R by non-hematopoietic tumors cells was controversial because the presence of inflammatory cells, which can express Fc γ R, was demonstrated early at the tumor site [ 54 ] and because Fc γ R expression was lost during short-term tumor cell in vitro culture [ 55 ]. Nevertheless, it was shown that the experimental tumors regained expression after a single passage in vivo [ 56 ] and that some tumor cell lines express Fc γ R [ 57 ].…”
Section: Expression Of Tumor Fc γ Riibmentioning
confidence: 99%
“…Although Wood & Gollahon (1977) demonstrated Fc(IgG) receptor-bearing cells in breast tumours, some investigators believe that malignant cells can express such receptors (Tonder & Thunold, 1973;Svennevig & Andersson, 1982). Morphologically, macrophages are not readily delineated in tissue sections of carcinomas, and in tumour cell suspensions precise identification is likewise difficult.…”
mentioning
confidence: 99%
“…Although the Fc(IgG) receptor has been widely used as a macrophage marker in tumour cell suspensions (Russell et al, 1981), some workers have suggested that malignant cells themselves may express Fc(IgG) receptors (Tonder & Thunold, 1973;Svennevig & Andersson, 1982). In addition, it has been shown that human monocytes can shed these receptors in culture (Kay & Douglas, 1981), raising the possibility of nonspecific receptor uptake by tumour cells.…”
mentioning
confidence: 99%
“…In addition, it was observed that tumor cells injected in mice immunized with non-tumoral antigens were able to bind antibody via their Fc region [42]. However, the ectopic expression of FcγRs by nonhematopoietic tumor cells was controversed because the presence of inflammatory cells, which can express FcγRs, was quickly demonstrated at the tumor site [43] and because FcγR expression was lost during short-term culture of tumor cells in vitro [44]. Nevertheless, it was shown that the experimental tumors regained this expression after a single passage in vivo [45] and that some tumor cell lines expressed FcγRs [46].…”
Section: Ectopic Expression Of Fcγr On Non-hematopoietic Tumor Cellsmentioning
confidence: 94%